Antibody binding affinity ligands

Details for Australian Patent Application No. 2005318700 (hide)

Owner Novo Nordisk A/S

Inventors Johannsen, Ib; Ambrosius, Dorothee; Michael, Roice; Jacobi, Alexander; Nothelfer, Franz; Gallego, Monica Ramos

Agent FB Rice

Pub. Number AU-B-2005318700

PCT Pub. Number WO2006/066598

Priority 60/643,314 13.01.05 US; PA 2004 02010 23.12.04 DK

Filing date 23 December 2005

Wipo publication date 29 June 2006

Acceptance publication date 14 April 2011

International Classifications

C07K 5/10 (2006.01) Peptides having up to four amino acids in a fully defined sequence

C07K 5/08 (2006.01) Peptides having up to four amino acids in a fully defined sequence

G01N 33/543 (2006.01) Investigating or analysing materials by specific methods not covered by groups - with an insoluble carrier for immobilising immunochemicals

Event Publications

19 July 2007 PCT application entered the National Phase

  PCT publication WO2006/066598 Priority application(s): WO2006/066598

14 April 2011 Application Accepted

  Published as AU-B-2005318700

11 August 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005318723-Method for production of a thin-layer solar cell with microcrystalline silicon and layer sequence

2005318698-Hybrid enzymes consisting of an endoamylase first amino acid sequence and a carbohydrate -binding module as second amino acid sequence